MX2023000854A - Formulacion de jeringa precargada con aguja con protector de aguja que contiene nuevo anticuerpo modificado. - Google Patents

Formulacion de jeringa precargada con aguja con protector de aguja que contiene nuevo anticuerpo modificado.

Info

Publication number
MX2023000854A
MX2023000854A MX2023000854A MX2023000854A MX2023000854A MX 2023000854 A MX2023000854 A MX 2023000854A MX 2023000854 A MX2023000854 A MX 2023000854A MX 2023000854 A MX2023000854 A MX 2023000854A MX 2023000854 A MX2023000854 A MX 2023000854A
Authority
MX
Mexico
Prior art keywords
needle
prefilled syringe
syringe preparation
modified antibody
including novel
Prior art date
Application number
MX2023000854A
Other languages
English (en)
Inventor
Robert Mueller
Yuji Yamanaka
Kewei Yang
Masakazu Fukuda
Shogo Yamashita
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of MX2023000854A publication Critical patent/MX2023000854A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202—Devices for protection of the needle before use, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Peptides Or Proteins (AREA)

Abstract

El objetivo de la presente descripción es proporcionar una formulación de jeringa precargada con aguja insertada que contiene un anticuerpo diseñado por una mutación de histidina, lo que reduce la dificultad para expulsar un fármaco y el riesgo de provocar una obstrucción en una aguja. La formulación de jeringa precargada con aguja insertada se puede producir mediante un método simple a escala industrial. La presente formulación de jeringa precargada se caracteriza por tener un protector de aguja elastomérico que tiene una baja capacidad de lixiviación de zinc.
MX2023000854A 2020-07-28 2021-07-27 Formulacion de jeringa precargada con aguja con protector de aguja que contiene nuevo anticuerpo modificado. MX2023000854A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020127605 2020-07-28
PCT/JP2021/027663 WO2022025030A1 (ja) 2020-07-28 2021-07-27 新規改変型抗体を含む、針シールドを備えた針付プレフィルドシリンジ製剤

Publications (1)

Publication Number Publication Date
MX2023000854A true MX2023000854A (es) 2023-02-15

Family

ID=80036593

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000854A MX2023000854A (es) 2020-07-28 2021-07-27 Formulacion de jeringa precargada con aguja con protector de aguja que contiene nuevo anticuerpo modificado.

Country Status (11)

Country Link
EP (1) EP4190354A1 (es)
JP (1) JPWO2022025030A1 (es)
KR (1) KR20230047397A (es)
CN (1) CN116194473A (es)
AU (1) AU2021315210A1 (es)
BR (1) BR112023000216A2 (es)
CA (1) CA3186914A1 (es)
IL (1) IL300182A (es)
MX (1) MX2023000854A (es)
TW (1) TW202220694A (es)
WO (1) WO2022025030A1 (es)

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201994A (ja) 1982-05-21 1983-11-25 Hideaki Hagiwara 抗原特異的ヒト免疫グロブリンの生産方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
WO1992020791A1 (en) 1990-07-10 1992-11-26 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
DK0605522T3 (da) 1991-09-23 2000-01-17 Medical Res Council Fremgangsmåde til fremstilling af humaniserede antistoffer
ES2227512T3 (es) 1991-12-02 2005-04-01 Medical Research Council Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
CA2124967C (en) 1991-12-17 2008-04-08 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
JP3507073B2 (ja) 1992-03-24 2004-03-15 ケンブリッジ アンティボディー テクノロジー リミティド 特異的結合対の成員の製造方法
CA2140638C (en) 1992-07-24 2010-05-04 Raju Kucherlapati Generation of xenogeneic antibodies
CA2161351C (en) 1993-04-26 2010-12-21 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
EP0731842A1 (en) 1993-12-03 1996-09-18 Medical Research Council Recombinant binding proteins and peptides
EP0770628B9 (en) 1994-07-13 2007-02-28 Chugai Seiyaku Kabushiki Kaisha Reconstituted human antibody against human interleukin-8
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP0823941A4 (en) 1995-04-28 2001-09-19 Abgenix Inc HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
CN101939425B (zh) 2007-09-26 2014-05-14 中外制药株式会社 抗il-6受体抗体
SG10201605394SA (en) 2007-09-26 2016-08-30 Chugai Pharmaceutical Co Ltd Modified Antibody Constant Region
EP3689912A1 (en) 2007-09-26 2020-08-05 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substitution in cdr
BRPI0817637A2 (pt) 2007-09-28 2015-09-08 Chugai Pharmaceutical Co Ltd anticorpo anti-glipican-3 tendo cinéticas aperfeiçoadas no plasma
RU2531521C2 (ru) 2007-12-05 2014-10-20 Чугаи Сейяку Кабусики Кайся Антитело против nr10 и его применение
EP4238993A3 (en) 2008-04-11 2023-11-29 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
CA2963325A1 (en) 2014-10-30 2016-05-06 F. Hoffmann-La Roche Ag Syringe and method of preparing a syringe
US20180133375A1 (en) 2014-10-30 2018-05-17 Chugai Seiyaku Kabushiki Kaisha Pre-Filled Syringe Formulation With Needle, Which Is Equipped With Syringe Cap
KR101674438B1 (ko) 2014-12-05 2016-11-09 이승한 프로젝트 발주 및 프로젝트의 컴포넌트 개발을 위한 플랫폼 운영 시스템 및 그 방법
WO2017038463A1 (ja) 2015-08-31 2017-03-09 ソニー株式会社 送信装置、および送信方法、情報処理装置、および情報処理方法、並びにプログラム
PE20181336A1 (es) * 2015-09-18 2018-08-21 Chugai Pharmaceutical Co Ltd Anticuerpos que se unen a interleucina 8 (il-8) y sus usos

Also Published As

Publication number Publication date
JPWO2022025030A1 (es) 2022-02-03
CA3186914A1 (en) 2022-02-03
TW202220694A (zh) 2022-06-01
WO2022025030A1 (ja) 2022-02-03
KR20230047397A (ko) 2023-04-07
BR112023000216A2 (pt) 2023-02-07
IL300182A (en) 2023-03-01
AU2021315210A1 (en) 2023-03-09
EP4190354A1 (en) 2023-06-07
CN116194473A (zh) 2023-05-30

Similar Documents

Publication Publication Date Title
JOP20170042B1 (ar) وسيلة توصيل عقار، طريقة تصنيعه وطريقة استخدامه
MX2018012290A (es) Dispositivo de administracion de farmaco, metodo de fabricacion y metodo de uso.
WO2017180480A8 (en) Accurate, precise microliter dosing syringe
GB1300163A (en) Improvements in syringes
MX2022004268A (es) Cartucho para un autoinyector y metodos relacionados.
BR112021016439A2 (pt) Autoinjetor com indicador de áudio
GB1108900A (en) Disposable syringe
GB836279A (en) Syringe push rod
MX2023000854A (es) Formulacion de jeringa precargada con aguja con protector de aguja que contiene nuevo anticuerpo modificado.
EA201990228A1 (ru) Система инъекции имплантата/медикамента на основе защитного корпуса
GB1166050A (en) Improvements in or relating to Syringes
CN205698711U (zh) 一种具有输注报警功能的胰岛素泵
NZ630468A (en) Re-useable injector device for syringe
Ramus et al. Use of intravenous and subcutaneous human immunoglobulins
EA202190815A1 (ru) Инъекторная пружина для состаренного, предварительно заполненного шприца и автоинъектор
Schütz‐Fuhrmann et al. Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial.
Mergenthal et al. Delegation of GP work to qualified medical staff in germany-an overview
Franques et al. Metabolic and nutritional neuropathies: update in diabetes, vitamin B12 and copper deficiency
Wong et al. Ease of use of two reusable, half-unit increment dosing insulin pens by adult caregivers of children with type 1 diabetes: a randomized, crossover comparison
TWD204534S (zh) 注射器及其柱塞
Song et al. PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells
Sun et al. Urolastic: A new medical liquid silicone rubber elastomer compound for penile augmentation in beagle dogs
GB712861A (en) Injection syringe
ES29670U (es) Obturaciones perfeccionadas para émbolos de jeringas de inyecciones
NZ776065A (en) Pre-filled safety needle and syringe system